Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pegylated glucagon and GLP-1 co-agonists for the treatment of obesity

Pegylated glucagon and GLP-1 co-agonists for the treatment of obesity

US Patent 9714277 · Granted Jul 25, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptides and uses thereof2025
Glucagon/GLP-1 agonists for the treatment of obesity2022
Glucagon and GLP-1 co-agonists for the treatment of obesity2020
Glucagon/GLP-1 agonists for the treatment of obesity2020
Protease-resistant lipidated GLP-1 analogs2019
Glucagon/GLP-1 agonists for the treatment of obesity2017
Melanin-concentrating hormone antagonists2008
Melanin-concentrating hormone analogs2008
Selective melanin-concentrating hormone type-1 receptor agonists2007
Melanin-concentrating hormone analogs2007
Ghrelin analogs2005
Cyclic peptides as potent and selective melanocortin-4 receptors agonists2005